WO2026045348 - HEDERASAPONIN COMPOSITION, HEDERA LEAF EXTRACT COMPRISING COMPOSITION, AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/045348
Publication Date
05.03.2026
International Application No.
PCT/CN2025/092257
International Filing Date
30.04.2025
Title **
[English]
HEDERASAPONIN COMPOSITION, HEDERA LEAF EXTRACT COMPRISING COMPOSITION, AND USE THEREOF
[French]
COMPOSITION D'HÉDÉRASAPONINE, EXTRAIT DE FEUILLE D'HEDERA COMPRENANT UNE COMPOSITION ET SON UTILISATION
[Chinese]
常春藤皂苷组合物、包括组合物的常春藤叶提取物及其应用
Applicants **
ZHEIJIANG CONBA CHINESE MEDICINE CO., LTD.
Inventors
CHEN, Qing
YAO, Jianbiao
PING, Xiating
JIN, Zhiwen
YE, Guanzeng
LAN, Wenyi
PANG, Jinping
ZHU, Chaoqun
SUN, Lei
ZHOU, Xiang
JIN, Huihui
LU, Xiaowei
Priority Data
202411192901.5
28.08.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1721 | |
| EPO | Filing, Examination, Granting | 11606 | |
| Japan | Filing, Examination, Granting | 2174 | |
| South Korea | Filing, Examination, Granting | 2115 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,356
Contact Us
Abstract[English]
A hederasaponin composition and a hedera leaf extract. The hederasaponin composition comprises hederasaponin C, α-hederasaponin, hederasaponin B, and hederasaponin D in a mass ratio of 12-25:5-10:1:1-2. The hederasaponin composition and the hedera leaf extract can be used for preparing drugs for treating or preventing acute bronchitis, expectorants, and antitussives.[French]
L'invention concerne une composition d'hédérasaponine et un extrait de feuille d'Hedera. La composition d'hédérasaponine comprend de l'hederasaponine C, de l'α-hédérasaponine, de l'hédérasaponine B, et de l'hédérasaponine D dans un rapport massique de 12-25 : 5-10 : 1 : 1-2. La composition d'hédérasaponine et l'extrait de feuille d'Hedera peuvent être utilisés pour préparer des médicaments pour traiter ou prévenir une bronchite aiguë, des expectorants et des antitussifs.[Chinese]
一种常春藤皂苷组合物以及常春藤叶提取物，包括质量比为12～25：5～10：1：1～2常春藤皂苷C、α-常春藤皂苷、常春藤皂苷B和常春藤皂苷D。常春藤皂苷组合物以及常春藤叶提取物可用于制备治疗或预防急性支气管炎药物和祛痰、镇咳药物。